^
    BIOMARKER:

    HER-2 overexpression

    i
    Other names: ERBB2, CD340, HER-2, HER2, NEU, NGL, V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2
    Contact us to learn more about our Premium Content:
    News alerts, weekly reports and conference planners
    Entrez ID:
    2064
    Related biomarkers:
    Expression
    Mutation
    CNA
    Fusion
    Others
    HER-2 overexpression
    Ovarian Cancer
    fam-trastuzumab deruxtecan-nxki
    Sensitive
    :
    D
    IGCS 2022 - 2 weeks - (New D)
    HER-2 overexpression
    Non Small Cell Lung Cancer
    fam-trastuzumab deruxtecan-nxki
    Sensitive
    :
    C2
    ESMO 2022 - 3 weeks - (New C3)
    HER-2 overexpression
    Gastric Cancer
    trastuzumab
    Sensitive
    :
    A1
    HER-2 overexpression
    Hormone Receptor Positive Breast Cancer
    trastuzumab-qyyp
    Sensitive
    :
    A1
    HER-2 overexpression
    HER2 Positive Breast Cancer
    trastuzumab-qyyp
    Sensitive
    :
    A1
    HER-2 overexpression
    Gastric Cancer
    trastuzumab-qyyp
    Sensitive
    :
    A1
    HER-2 overexpression
    Hormone Receptor Positive Breast Cancer
    trastuzumab-dttb
    Sensitive
    :
    A1
    HER-2 overexpression
    HER2 Positive Breast Cancer
    trastuzumab-dttb
    Sensitive
    :
    A1
    HER-2 overexpression
    Gastric Cancer
    trastuzumab-dttb
    Sensitive
    :
    A1
    HER-2 overexpression
    Hormone Receptor Positive Breast Cancer
    trastuzumab-dkst
    Sensitive
    :
    A1
    HER-2 overexpression
    HER2 Positive Breast Cancer
    trastuzumab-dkst
    Sensitive
    :
    A1
    HER-2 overexpression
    Gastric Cancer
    trastuzumab-dkst
    Sensitive
    :
    A1
    HER-2 overexpression
    Hormone Receptor Positive Breast Cancer
    trastuzumab-anns
    Sensitive
    :
    A1
    HER-2 overexpression
    HER2 Positive Breast Cancer
    trastuzumab-anns
    Sensitive
    :
    A1
    HER-2 overexpression
    Gastric Cancer
    trastuzumab-anns
    Sensitive
    :
    A1
    HER-2 overexpression
    Gastric Cancer
    trastuzumab-pkrb
    Sensitive
    :
    A1
    HER-2 overexpression
    Hormone Receptor Positive Breast Cancer
    trastuzumab-pkrb
    Sensitive
    :
    A1
    HER-2 overexpression
    HER2 Positive Breast Cancer
    trastuzumab-pkrb
    Sensitive
    :
    A1
    HER-2 overexpression
    Hormone Receptor Positive Breast Cancer
    lapatinib
    Sensitive
    :
    A1
    HER-2 overexpression
    Hormone Receptor Negative Breast Cancer
    trastuzumab + lapatinib
    Sensitive
    :
    A1
    HER-2 overexpression
    Breast Cancer
    lapatinib
    Sensitive
    :
    A1
    HER-2 overexpression
    Breast Cancer
    trastuzumab
    Sensitive
    :
    A1
    HER-2 overexpression
    Breast Cancer
    trastuzumab / hyaluronidase-oysk
    Sensitive
    :
    A1
    HER-2 overexpression
    Hormone Receptor Positive Breast Cancer
    neratinib
    Sensitive
    :
    A1
    HER-2 overexpression
    Breast Cancer
    trastuzumab-dttb
    Sensitive
    :
    A1
    HER-2 overexpression
    Breast Cancer
    trastuzumab-qyyp
    Sensitive
    :
    A1
    HER-2 overexpression
    Breast Cancer
    trastuzumab-pkrb
    Sensitive
    :
    A1
    HER-2 overexpression
    Breast Cancer
    trastuzumab-anns
    Sensitive
    :
    A1
    HER-2 overexpression
    Breast Cancer
    trastuzumab-dkst
    Sensitive
    :
    A1
    HER-2 overexpression
    HER2 Positive Breast Cancer
    trastuzumab
    Sensitive
    :
    A1
    HER-2 overexpression
    Breast Cancer
    Zercepac (trastuzumab biosimilar)
    Sensitive
    :
    A1
    HER-2 overexpression
    Gastroesophageal Junction Adenocarcinoma
    trastuzumab
    Sensitive
    :
    A1
    HER-2 overexpression
    Gastric Cancer
    Zercepac (trastuzumab biosimilar)
    Sensitive
    :
    A1
    HER-2 overexpression
    Breast Cancer
    trastuzumab + docetaxel
    Sensitive
    :
    A1